Internationally-recognized ‘We Invest in People’ award is certified recognition of the our care and commitment to employees globally.
Cambridge, UK [14 June, 2024]: Sphere Bio, a leading provider of innovative microfluidics-based solutions for single-cell analysis and isolation, today announced that it has received the ‘We invest in people’ Gold accreditation, a prestigious award presented by Investors in People (IIP). This accolade is in recognition of the Company’s commitment to excellence in people management and continuous improvement in workplace practices.
The IIP framework is a globally-recognized standard for people management, defining what it takes to lead, support, and manage people effectively to achieve sustainable results. Presentation of the Gold accreditation signifies how Sphere Bio has not only met but surpassed the high standards set by IIP when assessing the Company’s practices, policies overall approach to investment in people. The award demonstrates an outstanding commitment to empowering employees, fostering an inclusive culture, and driving performance through effective leadership and management practices.
Sphere Bio has always placed a high priority on the well-being and development of its employees, understanding that a motivated and engaged workforce is essential for driving innovation and achieving strategic goals. This prestigious award is a reflection of the Company’s robust HR practices, including comprehensive professional development programs, a strong emphasis on work-life balance, and an inclusive, collaborative workplace environment. For more information, you can read our company commitment, promise and values on the about us page.
Dale Levitzke, CEO of Sphere Bio, expressed his pride in the achievement:
“Receiving the Gold Investors in People Award is a significant milestone for Sphere Bio. It recognizes the dedication and hard work of our entire team in creating a workplace where people feel valued, supported, and empowered to reach their full potential. This award is not just a tribute to our HR practices, but a testament to our commitment to nurturing a culture of excellence and continuous improvement.”
Denise Emsden, VP of People & Organizational Development, Sphere Bio added:
“We are extremely proud to receive this award; a reflection of the dedication to our team and desire to ensure Sphere Bio is a great place to work for all our employees. It’s an honor to receive this recognition of our commitment and ambition to deliver important benefits and support to our team.”
For more information contact:
Dr Claire Cox
Sphere Bio Ltd.
Tel: +44 (0)7365 209 441
Email: claire.cox@spherebio.com
Zyme Communications
Lily Jeffery
Tel: +44 (0)7891 477 378
Email: lily.jeffery@zymecommunications.com
About Sphere Bio
Sphere Bio develops and manufactures single cell analysis and monoclonality assurance systems to enable researchers to find, analyze and isolate the most valuable cells, with ease and speed.
Sphere Bio’s proprietary picodroplet microfluidic platforms are designed specifically for single-cell screening and isolation, allowing users to encapsulate and analyze single cells within a picodroplet, while maintaining viability. Harnessing this technology, the Company’s range of novel microfluidic tools facilitate leading-edge research and accelerate biotherapeutic discovery and development, cell therapy, and synthetic biology workflows, streamlining the journey of discovery in labs, globally.
Sphere Bio is based at Granta Park in Cambridgeshire (UK). The Company has also internationalized its business via a global network of distributors.
For more information contact:
